Professional Experience
- Resident Doctor, Nephrology Division, IRCCS G. Gaslini (since July 2022)
- Medical Doctor and Research Scientist, Molecular Nephrology Laboratory, IRCCS G. Gaslini (February 2010 – June 2022)
 

Research Activities
- Principal Investigator – Ricerca Finalizzata 2016
- OFA3 Trial: “Efficacy of humanized monoclonal anti-CD20 antibodies (Ofatumumab) in the treatment of childhood steroid-dependent nephrotic syndrome and development of cell biomarkers predicting outcome” (PE-2016-02361576)
- International Research Projects (PI, Co-investigator, Coordinator):
- CureGN (since 2014 – PI)
- GIGA-kids (since 2014 – PI)
- UROGE-1 (since 2022 – PI, collaboration with Columbia University)
- 4-C project (since 2016 – contributor)
- esCapeKD (since 2023 – PI, collaboration with ESCAPE and ERKNet)
- ERKNET register (since 2018 – PI, European rare kidney disease network)
- Industry-funded Clinical Trials (Investigator or PI):
- FIONA (Bayer)
- FIONAOLE (Bayer)
- INSHORE (Roche)